Home / Market News / $A
benzinga Corporate Catalyst Impact 85/100 ● positive

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist

Oct 14, 2026, 1:29 PM UTC · Primary ticker $A

Agilent Technologies is acquiring Proscia, an AI-powered digital pathology software provider, for up to $270 million. This strategic move aims to expand Agilent's presence in AI-enabled diagnostics, strengthen its digital pathology capabilities, and enhance its long-term growth profile through recurring software revenue.

Agilent Technologies is acquiring Proscia, a digital pathology software provider, for $240 million cash at closing plus $30 million in performance milestones. This acquisition is significant as it directly expands Agilent's capabilities in the rapidly growing field of AI-powered diagnostics and digital pathology, building on an existing partnership. It allows Agilent to offer more integrated laboratory workflows and strengthens its higher-margin, recurring-revenue software business, which is positive for long-term growth. The deal is expected to close in early fiscal 2027, and Agilent's stock saw a positive premarket reaction, indicating investor approval of this strategic move.

$A positive Strategic acquisition expands AI diagnostics
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.